Navigation Links
CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
Date:10/27/2011

HemoStase inventory that the Company did not believe it would be able to distribute.  

General, administrative, and marketing expenses for the third quarter of 2011 were $14.7 million compared to $11.4 million for the third quarter of 2010.  General, administrative, and marketing expenses for the third quarter of 2011 included approximately $1.1 million in costs related to the Company's business development activities, including the acquisition of Cardiogenesis.  

General, administrative, and marketing expenses for the first nine months of 2011 were $42.7 million compared to $36.9 million for the first nine months of 2010.  General, administrative, and marketing expenses for the first nine months of 2011 included approximately $4.1 million in costs related to the Company's acquisition of Cardiogenesis and other business development activities.  General, administrative, and marketing expenses for the first nine months of 2010 included approximately $542,000 in costs related to business development activities.

Research and development expenses were $1.7 million and $1.6 million for the third quarters of 2011 and 2010, respectively.  Research and development expenses were $5.1 million and $4.1 million for the first nine months of 2011 and 2010, respectively.  Research and development spending in 2011 was primarily focused on PerClot, SynerGraft® tissues and products, BioFoam® Surgical Matrix, and BioGlue.  

Acquired in-process research and development expense of $3.5 million in the third quarter of 2010 was related to an intangible asset for PerClot distribution and manufacturing rights in the U.S. and certain other countries in which PerClot does not have current regulatory approvals.  Therefore the cost allocated to the asset was expensed upon acquisition.

Other expense was $207,000 for the third quarter of 2011 compared to $3.3 million for the third quarter of 2010.  Other
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
2. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
3. CryoLife Reports Record Quarterly Revenues of $28.2 Million
4. CryoLife to Present at Upcoming Investor Conferences in New York
5. CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference
6. CryoLife Provides Initial 2010 Financial Guidance
7. CryoLife Enters into Worldwide Distribution and Manufacturing Agreements with Starch Medical for Novel Hemostatic Agent
8. CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive
9. CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results
10. CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
11. CryoLife to Present at Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... development and sale of patented biopharmaceutical medicine, modernized traditional ... (API) today announced the business and development progress at ... 1. Following the September 2014 JCM application (No. 51268) ...
(Date:1/22/2015)...  ResMed Inc. (NYSE: RMD ) today announced results ... quarter was $423.0 million, a 10 percent increase compared to ... on a constant currency basis). Net income was $91.2 million, ... December 31, 2013. Diluted earnings per share for the quarter ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015  Profil Institute for ... on diabetes and obesity, announced today a new textbook,  ... Development,  published by Springer, a leading global scientific publisher. ... analyze and illustrate techniques for use in early phase ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... 2012  B. Braun Medical Inc. (B. Braun), a leader in ... Food and Drug Administration (FDA) approval for 2g Cefazolin ... DUPLEX® Drug Delivery System . The FDA approval ... 2g Cefazolin dose to hospitals and other healthcare settings where ...
... ThermoGenesis Corp. (NASDAQ: KOOL ), a leading supplier ... stem cells, said today, it had received an initial order ... cord blood bank that will begin operations in Canada in ... organization that manages the supply of blood and blood products ...
Cached Medicine Technology:B. Braun Becomes the First to Deliver FDA-Approved 2g Cefazolin 2B. Braun Becomes the First to Deliver FDA-Approved 2g Cefazolin 3Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System 2Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System 3Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System 4
(Date:1/22/2015)... a seasoned and trusted leader who consistently delivers trendy dresses ... it lead the wedding dress industry into the future. Today, ... the global market. , “The CEO of VogueQueen is uniquely ... continuing the goal of operational excellence and giving back to ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... 2015 Joan Lunden, award-winning American journalist, ... the upcoming 32nd Annual Miami Breast Cancer Conference ... Resource®, LLC (PER®) , shares that “a fast-growing, virulent” ... if she had not followed up her clean mammogram ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... The 28th Annual Meeting and,Scientific Session of ... will be held at the Boston Marriott Copley ... SCIENTIFIC PROGRAM, Attending media will have access ... scientific debate. ISHLT,expects more than 2,000 attendees from ...
... the healing power of the Indian spice turmeric for ... this month by a leading dermatology journal stating that ... active ingredient of the exotic spice was probably a ... of Pennsylvania School of Medicine found that despite strong ...
... Several individuals,and organizations were honored at the ... (NJHA) today at the Hyatt Regency Princeton., ... George F.,Lynn, former chief executive officer of AtlantiCare ... for his years of service and leadership to,AtlantiCare ...
... In a couple where one of the partners is diagnosed ... men, regardless of whether they are the person with the ... paper appearing in the Psychological Bulletin report that when a ... gender plays a greater role than who the patient is. ...
... the most prevalent form of dementia in the Western ... society, some people are calling it the disease of ... playing a prominent role in researching the processes that ... for his work, both nationally and internationally − and ...
... a pump: that is the simple concept behind the ... of Technology (TU Delft) in The Netherlands. In this ... through a membrane using approximately 60 bar. This reverse ... windmill is suited for use by, for instance, small ...
Cached Medicine News:Health News:Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12 2Health News:Popular alternative therapy for psoriasis performs no better than placebo 2Health News:New Jersey Hospital Association Presents Awards for Commitment to Healthcare 2Health News:New Jersey Hospital Association Presents Awards for Commitment to Healthcare 3Health News:When couples face the diagnosis of cancer, women carry a larger emotional burden than men 2Health News:Bart De Strooper receives prestigious $200,000 Alzheimer Prize 2Health News:TU Delft tests windmill for seawater desalination 2
Near point card/newspaper 8 to 48 point type 5 1/2" X 8"....
It has the near point, Snellen X-CYL Jaeger & SMD cards in one set....
Near point card 4 1/2 to 24 PT 5 1/2" x 8"....
... provides references to many common print sizes, from ... size. This provides the examiner a starting point ... with black ink on yellow styrene for increased ... 20/20. Other notations include Jaeger, M notation, lower ...
Medicine Products: